Inovio Pharmaceuticals, Inc. (NYSE: INO) announced today the publication of positive immunological effects in preclinical animal models of optimized electroporation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE